1. B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
- Author
-
Hedenstedt, Anna, Reid, Sarah, Sayadi, Ahmed, Eloranta, Maija-Leena, Skoglund, Elisabeth, Bolin, Karin, Frodlund, Martina, Lerang, Karoline, Joensen, Andreas, Rantapaeae-Dahlqvist, Solbritt, Bengtsson, Anders A., Rudin, Anna, Molberg, Oyvind, Sjöwall, Christopher, Sandling, Johanna K., Leonard, Dag, Hedenstedt, Anna, Reid, Sarah, Sayadi, Ahmed, Eloranta, Maija-Leena, Skoglund, Elisabeth, Bolin, Karin, Frodlund, Martina, Lerang, Karoline, Joensen, Andreas, Rantapaeae-Dahlqvist, Solbritt, Bengtsson, Anders A., Rudin, Anna, Molberg, Oyvind, Sjöwall, Christopher, Sandling, Johanna K., and Leonard, Dag
- Abstract
ObjectiveB cell function and autoantibodies are important in SLE pathogenesis. In this work, we aimed to investigate the impact of cumulative SLE B cell genetics on SLE subphenotype and autoantibody profile.MethodsFemale patients with SLE (n=1248) and healthy controls (n=400) were genotyped using Illuminas Global Screening Array. Two polygenic risk scores (PRSs), one representing B cell genes and the other B cell activation genes, were calculated for each individual using risk loci for SLE in genes assigned to B cell-related pathways according to the Kyoto Encyclopedia of Genes and Genomes, Gene Ontology and Reactome Databases.ResultsDouble-stranded DNA (dsDNA) antibodies were more prevalent among patients with a high compared with a low SLE B cell PRS (OR 1.47 (1.07 to 2.01), p=0.018), and effect sizes were augmented in patients with human leucocyte antigen (HLA) risk haplotypes HLA-DRB1*03:01 and HLA-DRB1*15:01 (DRB1*03/15 -/- (OR 0.99 (0.56 to 1.77), p=0.98; DRB1*03/15 +/- or -/+ (OR 1.64 (1.06 to 2.54), p=0.028; and DRB1*03/15 +/+ (OR 4.47 (1.21 to 16.47), p=0.024). Further, a high compared with a low B cell PRS was associated with low complement levels in DRB1*03/15 +/+ patients (OR 3.92 (1.22 to 12.64), p=0.022). The prevalence of lupus nephritis (LN) was higher in patients with a B cell activation PRS above the third quartile compared with patients below (OR 1.32 (1.00 to 1.74), p=0.048).ConclusionsHigh genetic burden related to B cell function is associated with dsDNA antibody development and LN. Assessing B cell PRSs may be important in order to determine immunological pathways influencing SLE and to predict clinical phenotype., Funding Agencies|The authors thank the patients and controls for their participation. The authors are grateful to all persons involved in handling the samples, and in particular thank Cane Amcoff and Paulina Turesson for excellent technical support. DNA sequencing and geno; National Genomics Infrastructure (NGI) Sweden; Science for Life Laboratory
- Published
- 2023
- Full Text
- View/download PDF